Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
143,207,364
-
Share change
-
+2,180,326
-
Total reported value
-
$6,823,569,543
-
Put/Call ratio
-
23%
-
Price per share
-
$47.66
-
Number of holders
-
355
-
Value change
-
+$110,187,911
-
Number of buys
-
167
-
Number of sells
-
177
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q2 2024
As of 30 Jun 2024 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 355 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 143,207,364 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock Inc., Bellevue Group AG, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Tweedy, Browne Co LLC, and BVF INC/IL.
This table shows 353 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.